Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Advance ZincTek Limited ( (AU:ANO) ) has provided an announcement.
Advance ZincTek Limited has clarified that its zinc oxide products were not involved in the recent CHOICE sunscreen test failures. The company ceased supplying Wild Child Laboratories in 2022, and any products tested were likely made with alternative zinc oxide sources. ANO has raised concerns with the Therapeutic Goods Administration about unlicensed zinc oxide resellers, but no action has been taken. The company remains committed to consumer safety and quality, and recent tariff decisions in the USA may reduce the risk of increased tariffs.
The most recent analyst rating on (AU:ANO) stock is a Hold with a A$1.00 price target. To see the full list of analyst forecasts on Advance ZincTek Limited stock, see the AU:ANO Stock Forecast page.
More about Advance ZincTek Limited
Advance ZincTek Limited operates in the skincare industry, focusing on the production of high-quality zinc oxide for sunscreen and cosmetic applications globally.
Average Trading Volume: 7,443
Technical Sentiment Signal: Buy
Current Market Cap: A$69.54M
For an in-depth examination of ANO stock, go to TipRanks’ Overview page.